NVP-DKY709

CAS No. 2291360-73-9

NVP-DKY709( —— )

Catalog No. M28913 CAS No. 2291360-73-9

NVP-DKY709 is a potent IKZF2 inhibitor for the treatment of cancers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 254 In Stock
5MG 231 In Stock
10MG 370 In Stock
25MG 605 In Stock
50MG 732 In Stock
100MG 918 In Stock
200MG Get Quote In Stock
500MG 1841 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NVP-DKY709
  • Note
    Research use only, not for human use.
  • Brief Description
    NVP-DKY709 is a potent IKZF2 inhibitor for the treatment of cancers.
  • Description
    NVP-DKY709 is a potent IKZF2 inhibitor for the treatment of cancers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Apelin receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2291360-73-9
  • Formula Weight
    417.5
  • Molecular Formula
    C25H27N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 16.67 mg/mL (39.93 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Trifonov L, et al. An Expedient Synthesis of CMF-019: (S)-5-Methyl-3-{1-(pentan-3-yl)-2- (thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic Acid, a Potent Apelin Receptor (APJ) Agonist. Med Chem. 2018;14(7):688-694.
molnova catalog
related products
  • HET0016

    HET0016 is a potent and selective 20-HETE synthase inhibitor (IC50s: 17.7 nM, 12.1 nM, and 20.6 nM for recombinant CYP4A1-, CYP4A2-, and CYP4A3-catalyzed 20-HETE synthesis) and a selective CYP450 inhibitor, shown to inhibit angiogenesis and tumor growth.

  • Cyanidin 3-O-galacto...

    Cyanidin 3-O-galactopyranoside

  • Fulvotomentoside B

    Fulvotomentoside B is a saponin isolated from Lactobacillus flavus. Fulvotomentoside compounds can significantly reduce serum glutamate pyruvate transaminase (SGPT) and triacylglycerol (GT) levels in mice poisoned by CCl4, d-galactosamine (d-gal) and acetaminophen, and significantly alleviate liver pathology. damage.